| scholarly article | Q13442814 |
| P2093 | author name string | Vikas R Dharnidharka | |
| Jodi M Smith | |||
| Ruth A McDonald | |||
| Lynya Talley | |||
| Karen Martz | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney disease | Q1054718 |
| collaboration | Q1145523 | ||
| P304 | page(s) | 1037-1042 | |
| P577 | publication date | 2007-08-16 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry | |
| P478 | volume | 2 |
| Q36947285 | Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies |
| Q38723077 | Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury. |
| Q41873862 | BK polyoma viral infection in renal allograft recipients |
| Q37879442 | BK polyomavirus infection and nephropathy: the virus-immune system interplay. |
| Q41507670 | BK virus infection in pediatric renal transplantation |
| Q37616854 | BK virus nephropathy: a pediatric nephrologist's perspective |
| Q27009997 | Biologics in renal transplantation |
| Q38904012 | Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK. |
| Q93059757 | Higher Incidence of BK Virus Nephropathy in Pediatric Kidney Allograft Recipients with Alport Syndrome |
| Q37813410 | Infection and chronic allograft dysfunction |
| Q88295635 | Infectious disease risks in pediatric renal transplantation |
| Q37877256 | Leflunomide in renal transplantation. |
| Q38064945 | Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation |
| Q93218704 | Long-Term Outcomes of Kidney Transplantation in Children |
| Q38666173 | Long-term effects of paediatric kidney transplantation |
| Q38003050 | Management of polyomavirus-associated nephropathy in renal transplant recipients |
| Q37848137 | Monitoring and managing viral infections in pediatric renal transplant recipients |
| Q52685625 | Non-immunologic allograft loss in pediatric kidney transplant recipients. |
| Q38016973 | Obstructive uropathy is associated with polyomavirus viremia in pediatric kidney transplantation |
| Q40963564 | Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction |
| Q38940498 | Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe |
| Q44080265 | Pretransplant IgG antibodies to polyoma BK virus in pediatric renal transplants |
| Q83052380 | Reducing the risk of viral infection in renal transplantation |
| Q38538684 | Renal transplantation in infants |
| Q33397668 | Sirolimus in pediatric renal transplantation |
| Q34178090 | Small Circular DNAs in Human Pathology |
| Q38071546 | Steroid withdrawal in renal transplantation |
| Q37821326 | The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment |
| Q33637476 | The need for tolerance in pediatric organ transplantation |
| Q38187175 | Tissue-resident T cells, in situ immunity and transplantation. |
| Q37624684 | Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview |
| Q57456436 | Urologic Evaluation and Management of Pediatric Kidney Transplant Patients |
| Q38240085 | Viral surveillance and subclinical viral infection in pediatric kidney transplantation. |
Search more.